Regencell Bioscience Lim... (RGC)
NASDAQ: RGC
· Real-Time Price · USD
850.50
-26.50 (-3.02%)
At close: Jun 02, 2025, 9:57 AM
Regencell Bioscience Revenue
Regencell Bioscience reported an annual revenue of $0, reflecting a 0% growth. For the quarter ending June 30, 2024, Regencell Bioscience generated $0 in revenue.
Revenue (ttm)
$0
Revenue Growth
0%
Price / Sales Ratio
0
Revenue / Employee
$0
Employees
12
Market Cap
11.07B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | % Change |
---|